Mild cognitive impairment, or MCI, is a condition wherein a person experiences minor changes in memory and cognitive function, but not to the degree of disability or impairment seen in dementia. It is not a disease or a symptom of dementia; rather, it is a pattern of cognitive changes that can be caused by disease, injury, or aging. While many patients do not progress to dementia, they may experience changes in mental abilities that can impact daily life. One of the most commonly reported symptoms of MCI is difficulty with short-term memory, such as remembering lists, Where a person put their items, Or new names or information. MCI can also affect a person’s problem-solving abilities or the ability to interpret and respond to new situations. Other common signs include difficulty with planning and organization, making decisions, and recalling information learned previously. MCI is diagnosed through a variety of tests, including memory and cognitive tests, physical exams, blood tests, psychological assessments, and imaging tests. Treatment depends on the cause of the MCI. If the cause is a reversible condition, such as depression, lifestyle changes and medications may be recommended. If a physical condition is identified, such as a thyroid disorder or vitamin deficiency, treatment may be necessary. In some cases, no cause can be identified and treatment focuses on managing the cognitive impairment. Management strategies may include lifestyle modifications such as continuing to exercise and engaging in regular cognitive activity. Memory aids and assistance with organization and decision making can also be helpful. Medications for cognitive problems in other conditions (such as Alzheimer’s disease) are not recommended as they have not been found to improve memory or reduce the risk of progressing to dementia. For those with mild cognitive impairment, living a healthy lifestyle, staying socially engaged, and continuing to employ problem-solving and cognitive strategies is essential for managing MCI.
Title : Scalp acupuncture with functional electrical stimulation for the treatment children with autism spectrum disorder
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy, Australia
Title : A structure-based strategy to target pathogenic α-synuclein in Parkinson’s disease
Salvador Ventura, Autonomous University of Barcelona, Spain
Title : Rabies: Challenges in taming the beast
Alan C Jackson, University of Calgary, Canada
Title : Designing and managing intelligent and ethical transformed health and social care ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Understanding Alzheimer's disease biomarkers across diverse populations - Opportunities and Insights for novel prevision medicine approaches
Sid O Bryant, Texas College of Osteopathic Medicine and University of North Texas Health Science Center Fort Worth, United States